The Board of Directors oversees the business of Cancer Council SA, the business name of the Anti-Cancer Foundation of South Australia (the ‘Company’).
The Board’s key objectives are to:
- Set the strategic directions for Cancer Council SA and effective oversight of management.
- Optimise Cancer Council SA's performance and stakeholder value within a framework of appropriate risk assessment and management.
- Recognise Cancer Council SA's legal and other obligations to all legitimate stakeholders.
To achieve these objectives, the Board is committed to working towards best corporate governance practices.
Corporate governance is concerned with the way that the Directors ensure that the organisation’s systems and processes are properly controlled and functioning effectively and that management is complying with the Board's policies and directives.
To assist the Board to meet their statutory and fiduciary obligations, it is supported by four board committees. The role of each committee is outlined below.
Nomination and Remuneration Committee
- Reviews and make recommendations to the Board on the structure of remuneration packages and policies applicable to the Chief Executive, senior executives and staff. The Board utilises a company-wide process for determining remuneration. The services of an external remuneration consultant are used to conduct benchmarking.
- Reviews remuneration policy and compliance with approved policy.
- Monitors succession planning and development, company culture and implementation of and compliance with the Organisation Development Policy.
- Monitors and reviews the composition of the Board, recommends nominations to the Board, and manages the Director and Board performance evaluation process.
Audit and Risk Committee
The primary responsibility of the Committee is to assist the Board of Directors in fulfilling its responsibilities in relation to the identification of areas of significant business risks and the monitoring of:
- Effective management of financial business risks
- Reliable management reporting
- Compliance with laws and regulations in respect to financial reporting
- Maintenance of an effective and efficient audit
- Related party transactions
- The protection of physical and financial assets.
The role of the Investment Committee is to recommend investment policy, review the appointment and performance of fund managers, monitor compliance with investment policy and monitor risk control limits.
Management of Investments
Cancer Council SA maintains a diversified portfolio in accordance with its Investment policy. Available for sales assets are held with Macquarie Private Wealth, Warakirri Asset Management, Nikko Asset Management Limited and Maple Brown Abbott Limited, Australia and New Zealand Banking Group Limited and Commonwealth Bank of Australia
Cancer Research Committee
The role of the Cancer Research Committee is to support the strategic research targets of Cancer Council SA by monitoring and assessing investments in cancer research and making recommendations to the Board on funding options.
Conflict of interest
There is an expectation in the community that the Boards of organisations like Cancer Council SA will operate in a transparent manner using best practice standards for corporate governance.
The Board recognises that proactive management of actual conflicts of interest will significantly reduce legal risks for individual Board members and the Board as a whole. Inadequate management of perceived conflicts of interest may damage the reputation and effectiveness of individual Board members, the Board and Cancer Council SA.
Therefore the Board has implemented a systematic and transparent process for dealing appropriately with each case. The Board recognises that it is not possible to eliminate every possible conflict of interest that may arise and have affect on Board and Board committee members.
The Cancer Council SA’s Risk Management philosophy is as much about grasping opportunities and creating successes as it is about minimising losses. Risk is therefore as much about something good not happening as something bad happening. The goal is not to eliminate all risk but rather to ensure that risk is maintained at an acceptable level in a cost effective manner.
Risk Management requires:
- forward thinking and a pro-active approach to management
- achieving a balance between the costs of managing risk and the anticipated benefits and
- using a formal systematic approach of identifying, analysing, evaluating, treating, monitoring and communicating risks associated with any activity, function or process.
This will facilitate decision making, ensure good governance through the performance and accountability of all employees and will also assist to ensure resources are properly allocated to manage those risks.
Cancer Council SA is committed to the management of all types of risks within its operations to assist in the achievement of its goals, programs, targets and its vision as outlined in the Strategic Management Plan.
Cancer Council SA will maintain risk management practices that provide it with a consistent, systematic view of the risk it faces in the course of its activities. These practices will be consistent with the guidelines and principles of risk management as set out in the Australian Risk Management Standard ISO 31000:2009 and business best practice.
Cancer Council SA’s Risk Management Framework and Methodology supports this Policy and will provide a formal, systematic approach to risk management which is consistent with the guidelines and principles of the Risk Management Standard.
Please view our Board of Director profiles below.
Rear Admiral The Honourable Kevin Scarce AC CSC RANR Rtd
- 1 November 2014
Kevin Scarce was born in Adelaide, educated at Elizabeth East Primary School and Elizabeth High School, before joining the Royal Australian Navy in 1968.
One of Kevin’s first postings at sea was in HMAS Sydney in Vietnam. In between his many and increasingly senior postings, Kevin completed a Bachelor of Financial Administration degree (1998), a Master of Management Economics degree at the University of NSW, ADFA campus (1990) and a Master’s Degree in National Security Strategy at the War College, US National Defense University in Washington DC (1994).
In his last appointment in the Australian Defence Force, Kevin temporarily led the Defence Materiel Organisation, which is responsible for acquiring and supporting the entire Australian Defence Force's military equipment throughout Australia and overseas.
Following retirement, Kevin formed and led the South Australian Government team charged with expanding the State's defence business opportunities. One of the team's first initiatives, to build Air Warfare Destroyers in Adelaide, was successfully achieved in May 2005 when the Federal Government awarded the contract to a locally based company.
In 2006 Kevin became an advisor and Board member of the Port Adelaide Maritime Corporation, formed to establish the State's shipbuilding infrastructure and associated skills base. He was also Chairman of the Board of Foundation Daw Park, which generates funding for medical research for veterans and older Australians.
Kevin was sworn in as the 34th Governor of South Australia on 8th August 2007, serving more than seven years in the Vice regal role.
Kevin was awarded the Conspicuous Service Cross in 1994 and appointed an Officer in the Military Division of the Order of Australia in 2004 and a Companion in the General Division of the Order of Australia in 2008 for his service to Australia’s defence industry and to the people of South Australia. In December 2009, Flinders University and Univesity of New England University have both bestowed an honorary Doctorate in recognition of his distinguished service to the nation and to the public of South Australia.
Professor Judith Dwyer BA, MBA, FAICD, FCHSM
- 10 November 2010
- Deputy Chairman - appointed 16 October 2012
Chairman, Cancer Research Committee
Member, Audit and Risk Committee
Member, Nomination and Remuneration Committee
Professor Dwyer is a health care management academic at the Flinders University School of Medicine, and a former CEO of Southern Health Care Network in Melbourne, and of Flinders Medical Centre in Adelaide, having worked in the Australian health system for more than 20 years. She is currently a Research Program Leader in the Cooperative Research Centre for Aboriginal and Torres Strait Islander Health. She conducts research focused on health system governance and design, does consulting work on related topics, and teaches in the Flinders’ Masters of Health Administration in Adelaide and in China.
Mr Jim Birch AM, BHA, FACHSM, AAICA
- 30 November 2012
Deputy Chairman, Cancer Research Committee
Mr Birch is currently an independent consultant and Non Executive Director of a number of Boards. He was formerly Ernst & Young’s Global Health Leader and Government and Public Sector Leader, Oceania. Mr Birch has been a Chief Executive of the Human Services and Health Department (South Australia), Deputy Chief Executive of Justice, and Chief Executive of major health service delivery organisations, including teaching hospitals.
Mr Birch is currently Deputy Chair of the Independent Hospital Pricing Authority, Chair of the Australian Red Cross Blood Service, a member of the Board of the Australian Red Cross Society, Chair of Mary MacKillop Care South Australia and a member of the Board of the Little Company of Mary Health Care.
Mr Greg Boulton AM BA (Accountancy) FCA, FCPA, FAICD
- 13 February 2015
Member, Investment Committee
Greg Boulton is Executive Chairman and a founder of Paragon, Private Equity.
Greg is a Fellow of the Institute of Chartered Accountants, CPA Australia and the Australian Institute of Company Directors.
He was Managing Director of IPEC Transport for seven years. After 20 years experience in senior management roles, he now consults on change management implementation, strategic planning, best practice programmes and transport. He is on the board of a number of private and public companies and has broad experience in capital raisings, acquisitions and commercial negotiations.
Greg is also on the board of Statewide Superannuation Fund, SA Motor Sports Board, K+S Transport Limited and Southern Gold Ltd., He was also the President of the Port Adelaide Football Club from1992 to 2008.
Greg has been awarded an AM – Member in the General Division in in the Order of Australia for his service to AFL administration, to the community of SA and to business.
The Hon Catherine Branson QC BA LLB (Adel) Hon LLD (Flin) Hon D Litt (Macq)
- 25 March 2015
Catherine Branson is a former judge of the Federal Court of Australia and the immediate past President of the Australian Human Rights Commission. Earlier in her career she held the positions of Crown Solicitor of South Australia and CEO of the Attorney-General’s Department (SA) before leaving public employment to practice as a barrister at the Adelaide Bar.
Catherine has served in many advisory and not-for-profit roles including as a member of the National Women’s Advisory Council, Board Member of the Queen Victoria Hospital, Deputy Chair of the Women’s and Children’s Hospital and President of the Australian Institute of Judicial Administration.
Mrs Belinda Jennings
- 18 August 2016
Mrs Jennings is a digital marketing professional and Founder of the Mum Central Network, harnessing the power of social media in the digital age to connect with Australia's most powerful consumers = mums.
She has a track record of delivering powerful, engaging and high value digital solutions to some of the world's leading brands and with her 20 years of marketing experience behind her, is passionate about connecting and educating brands on the benefits of digital and social media.
16 Tourism Awards past role as Director of Sales & Marketing for Unforgettable Houseboats and AusMumpreneur of the Year Awards and Women in Innovation (Technology finalist)
Mr Con Michalakis BSc(Ma) MSc
- 24 March 2011
Chairman, Investment Committee
Along with StatewideSuper's Investment Committee, Mr Michalakis is also responsible at StatewideSuper for managing $5.5 billion in funds under management.
Prior to joining StatewideSuper, Mr Michalakis was Director of Marketing and Client services for Manhattan-based boutique investment firm, Pzena Investment Management, where he was responsible for marketing the firm's products and services in Australia, New Zealand, Hong Kong and Singapore. He was previously the Director, Head of Institutional Business, for Merrill Lynch Investment Managers based in Sydney. Mr Michalakis has also worked in London with Alliance Capital Management and was the first Australian practice leader of investment consulting for Watson Wyatt.
Mr Michalakis has a Bachelor of Mathematical Science from the University of Adelaide, a Masters of Science from the University of London and is a Fellow at the Financial Services Institute of Australasia and a Post Graduate Diploma from the Said Business School, Oxford University.
Earlier in his career he worked in the finance and industrial relations sectors.
Associate Professor Susan Neuhaus CSC, MBBS, PhD FRACS
- 27 October 2010
Member, Audit and Risk Committee
Associate Professor Neuhaus is a General Surgeon and Fellow of the Royal Australasian College of Surgeons (RACS). In 2004 she was awarded the Lumley Exchange Scholarship and undertook a Fellowship in Surgical Oncology at the Royal Marsden Hospital in the United Kingdom. She has a Doctorate of Philosophy (PhD) in mechanisms of tumour spread during laparoscopy.
Associate Professor Neuhaus is a Clinical Associate Professor of the Department of Surgery, The University of Adelaide and works in private and public practice with special interests in melanoma and sarcoma. Associate Professor Neuhaus is a past Chair of the Surgical Oncology Group of the Clinical Oncological Society of Australia (COSA), Director of the Australasian Sarcoma Study Group (ASSG), member of the Australian Melanoma Trials Group (ANTMTG) and appointed to the Royal Australasian College of Surgeons Court of Examiners in General Surgery. She in actively involved in teaching, research and clinical trials and has published extensively, served as a journal editor and reviewer and authored a textbook ‘Radiology in Surgical Practice’. Susan has chaired the development and implementation of Australian Sarcoma Guidelines, introduced in 2013. She is a graduate of the Australian Institute of Company Directors.
Associate Professor Neuhaus has also completed an Army career spanning over 20 years. She has served Cambodia, Bougainville and Afghanistan. In 2009 she was awarded the Conspicuous Service Cross in the Queen’s Birthday Honours List in recognition of her leadership in Army Health. In 2012, she was a South Australian finalist for Australian of the Year. Susan remains actively involved in Veterans health issues, and has published extensively on strategic defence health issues. She has served on the Veterans Health Advisory Council (SA) and as an Ambassador for Defence Reserves. Susan is Chairman of the Board of the Repat Foundation and co-Patron of the RSL Virtual War Memorial. She also holds a position as Associate Professor in Conflict Medicine at the University of Adelaide.
Professor David Watson MBBS, MD, FRACS, FAHMS
- 14 October 2015
Since 2002, Professor David Watson has been Head of the Flinders University Department of Surgery and an Oesophageal and Gastric Surgeon at Flinders Medical Centre. Before joining Flinders University, he worked as a Consultant Surgeon at the Royal Adelaide Hospital for 9 years.
His clinical and research interests include gastro-oesophageal reflux and oesophageal and gastric cancer, and he has led 14 randomised clinical trials designed to improve clinical practice in these areas. He also leads molecular biology and population health research groups at Flinders University which work to improve early detection and prevention of gastrointestinal cancer. Professor Watson has published more than 300 research papers, more than 40 textbook chapters, and he has held many major research grants, including continuous funding from the National Health and Medical Research Council for more than 20 years. He has led the development of clinical guidelines for the management and prevention of oesophageal cancer for Cancer Council, and SA Health.
Professor Watson is a Senior Editor of the ANZ Journal of Surgery, and a member of the Editorial Boards for many other leading international journals including the British Journal of Surgery, Journal of Gastrointestinal Surgery, and World Journal of Surgery.
In 2006, Professor Watson led the establishment of the Australia and New Zealand Gastric and Oesophageal Surgery Association, and he served as the foundation President until 2010. He currently serves on the Board of Directors for the Australasian Gastrointestinal Trials Group, and as Secretary for the Executive Committee of the International Society for Diseases of the Esophagus.
In 2003, he was the recipient of the highest research award from the Royal Australasian College of Surgeons, the John Mitchell Crouch Fellowship, and in 2006 he was awarded a prestigious James IV Travelling Fellowship. In 2015 he was elected to Fellowship of the Australian Academy of Health and Medical Sciences, and appointed to a Matthew Flinders Distinguished Professorship at Flinders University.